Table 2.
Adjusted Relationship Between Select Characteristics With Willingness to Discuss PrEP With Pharmacy Staff and Screen for PrEP.a
| Pharmacy-Based PrEP Discussion |
Pharmacy-Based PrEP Screening |
|||||
|---|---|---|---|---|---|---|
| Prevalence Ratio (95% Confidence Interval) |
||||||
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
|
| ||||||
| Age | 1.02 (1.00–1.03) | 1.02 (1.00–1.03) | 1.01 (0.99–1.03) | 1.02 (1.00–1.03) | 1.01 (1.00–1.02) | 1.00 (0.99–1.01) |
| Race | ||||||
| White, non-Hispanic | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Black, non-Hispanic | 0.93 (0.60–1.43) | 0.91(0.59–1.41) | 0.97 (0.69–1.39) | 0.74 (0.51–1.08) | 0.67 (0.45–1.01) | 0.91 (0.78–1.06) |
| Hispanic | 0.90 (0.44–1.84) | 0.90 (0.44–1.83) | 0.86 (0.46–1.59) | 1.17 (0.54–2.51) | 1.14 (0.53–2.47) | 0.98 (0.75–1.29) |
| Income | ||||||
| <US$10K | 1.00 | 1.00 | 1.00 | 1.00 | ||
| US$10K–US$19K | 2.19 (0.97–4.97) | 1.59 (0.85–2.97) | 1.39 (0.80–2.42) | 1.11 (0.82–1.50) | ||
| US$20K–US$49K | 0.98 (0.60–1.59) | 0.96 (0.62–1.47) | 1.30 (0.85–1.98) | 1.08 (0.85–1.37) | ||
| ≥US$50K | 1.34 (0.77–2.35) | 1.29 (0.79–2.12) | 1.18 (0.77–1.81) | 1.09 (0.86–1.37) | ||
| Health insurance (yes) | 1.34 (0.77–2.35) | 1.41 (0.98–2.04) | 1.04 (0.72–1.51) | 1.00 (0.84–1.20) | ||
| PrEP interest (yes) | 1.65 (1.11–2.48) | 1.27 (1.09–1.48) | ||||
Abbreviation: PrEP, pre-exposure prophylaxis.
a
Model 1—adjusted for age and race; model 2—adjusted for age, race, income, and health insurance; model 3—adjusted for age, race, income, health insurance, and PrEP interest.